期刊文献+

外周血钙卫蛋白、环氧化酶-2水平变化与动脉血栓性疾病的关系 被引量:3

Relationship between S100A8/A9, COX-2 levels of peripheral blood and arterial thrombotic disease
原文传递
导出
摘要 目的 探讨外周血钙卫蛋白(S100A8/A9)、环氧化酶-2(COX-2)水平与动脉血栓性疾病的关系及其临床意义.方法 选取动脉血栓性疾病患者101例,其中急性心肌梗死患者50例,冠心病患者51例.25例健康体检者为对照组.采用酶联免疫吸附法(ELISA)检测各组血清S100A8/A9、COX-2水平,并分析S100A8/A9、COX-2水平间的相关性.结果 (1)动脉血栓性疾病患者外周血S100A8/A9、COX-2水平明显高于对照组;(2)急性心肌梗死组患者S100A8/A9、COX-2水平明显高于冠心病组;(3)急性心肌梗死组和冠心病组S100A8/A9水平与COX-2水平均无明显相关性.结论 心血管病患者外周血S100A8/A9、COX-2水平明显升高可能与疾病的发生、发展相关;S100A8/A9、COX-2可作为判断动脉血栓性疾病严重程度的参考指标之一. Objective To observe S100A8/A9,COX-2 levels in patients with arterial thrombotic disease and evaluate their relationships with arterial thrombotic diseases and their clinical significance.Methods There were 101 patients with arterial thrombotic disease in experimental group,including 50patients with acute coronary syndrome,51 patients with coronary heart disease.There were 25 cases in normal controls.Enzyme-linked immunosorbent assay ELISA was used to detect and compare the serum levels of S100A8/A9 and COX-2.Then the relevance between S100A8/A9 and COX-2 levels was tested.ELISA was used to analyze the expression of S100A8/A9,COX-2 in different groups.Results (1) The levels of S100A8/A9 and COX-2 in patients with arterial thrombotic disease were significantly higher.(2)The levels of S100A8/A9 and COX-2 in acute coronary syndrome group were significantly higher than CHD group.(3)There were no significant relevance between S100A8/A9 and COX-2 levels in both acute coronary syndrome group and CHD group.Conclusion Significantly elevated S100A8/A9,COX-2 levels in patients undergo cardiovascular disease may associate with the development of the disease.S100A8/A9,COX-2 can be used as a reference to judge the severity of arterial thrombotic disease.
出处 《临床内科杂志》 CAS 2014年第5期321-323,共3页 Journal of Clinical Internal Medicine
基金 上海市科委基金资助项目(124119a6800) 上海市公共卫生重点学科建设计划项目(12GWZX1002) 上海市教委基金资助项目(11YZ57)
关键词 动脉血栓性疾病 钙卫蛋白 环氧化酶-2 Arterial thrombotic diseases S100A8/A9 Cyclooxygenase-2
  • 相关文献

参考文献12

  • 1Surin WR,Prakash P,Barthwal MK,et al.Optimization of ferric chloride induced thrombosis model in rats:effect of anti-platelet and anticoagulant drugs[J] .J Pharmacol Toxicol Methods,2010,61 (3):287-291.
  • 2刘芳芳,翟振国,杨媛华,王军,王辰.血液中炎症相关指标的动态变化及其与静脉血栓栓塞症的相关性[J].中华医学杂志,2013,93(24):1860-1863. 被引量:11
  • 3Cai XY,Lu L,Wang YN,et al.Association of increased S100B,S100A6 and S100P in serum levels with acute coronary syndrome and also with the severity of myocardial infarction in cardiac tissue of rat models with ischemia-reperfusion injury[J] .Atherosclerosis,2011,217 (2):536-542.
  • 4Healy AM,Pickard MD,Pradhan AD,et al.Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events[J] .Circulation,2006,113 (19):2278-2284.
  • 5Morrow DA,Wang Y,Croce K,et al.Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy:Thrombolysis in Myocardial Infarction (PROVE IT-TI-MI 22) trial[J] .Am Heart J,2008,155 (1):49-55.
  • 6Mjelva OR,Brügger-Andersen T,P(o)nitz V,et al.Long-term prognostic utility of PAPP-A and calprotectin in suspected acute coronary syndrome[J] .Scand Cardiovasc J,2013,47(2):88-97.
  • 7Mosheimer BA,Kaneider NC,Feistritzer C,et al.CD40-ligannd-dependent induction of COX-2 gene expression in end the lial Cells by activated platelet inhibitory effects of atorvastatin[J] .Blood Coagul Fibrinolysis,2005,16(2):105-110.
  • 8Sanchez A,Contreras C,Martinez P,et al.Enhanced cyclooxygenase 2-mediated vasorelaxation in coronary arteries from insulin-resistant obese Zucker rats[J] .Atherosclerosis,2010,213 (2):392-399.
  • 9Altman R,Luciardi HL,Muntaner J,et al.Efficacy assessment of meloxicam,a preferential cyclooxygenase-2 inhibitor,in acute coronary syndromes without ST-segment elevation:the Nonsteroidal Anti-Inflammatory Drugs in Unstable Angina Treatment-2 (NUT-2) pilot study[J] .Circulation,2002,106(2):191-195.
  • 10刘恒方,李新华,杨期东,苗旺,齐尚书,宋喜明,何庚山,董洪林,张福全.人颈动脉粥样硬化斑块环氧化物酶-2及I型前列腺素合成酶的表达[J].中华医学遗传学杂志,2007,24(4):453-456. 被引量:5

二级参考文献26

  • 1刘恒方,黄晓松,刘尊敬,杨期东.颈动脉狭窄动物模型制作的研究进展[J].国际神经病学神经外科学杂志,2006,33(1):62-65. 被引量:24
  • 2刘恒方,杨期东,苗旺,朱晓岩,黄晓松.颈动脉硬化斑块环氧化物酶-2表达及其干预的实验研究[J].中华老年心脑血管病杂志,2006,8(10):700-702. 被引量:9
  • 3刘恒方,李新华,杨期东,苗旺,刘尊敬.改良硅橡胶圈加高胆固醇喂养诱导颈动脉狭窄兔模型的建立[J].中国实用神经疾病杂志,2007,10(1):17-19. 被引量:14
  • 4Holmes DR, Wester W, Thompson RW, et al. Prostaglandin E2 synthesis, and cyclooxygenase expression in abdominal aortic aneurysms. J Vasc Sttrg, 1997, 25:810-815.
  • 5Cipollone F, Fazia M, Iezzi A, et al. Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans. Arterioscler Thromb Vasc Biol,2004,24: 1259-1265.
  • 6Cipollone F,Fazia M, Iezzi A, et al. Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human. Arterioscler Thromb Vasc Biol,2005,25: 1925- 1931.
  • 7Cipollone F, Fazia M, Iezzi A, et al. Suppression of the functionally coupled cyclooxygenase-2/PGE synthase as a basis of simvastatin-dependent plaque stabilization in humans. Circulation, 2003, 107: 1479-1485.
  • 8Ajmone-Cat M, Nicolini A, Minghetti L. Prolonged exposure of microglia to lipopolysaccharide modifies the intracenular signaling pathways and selectively promotes prostaglandin E2 synthesis. J Neurochem, 2003, 87 : 1193- 1203.
  • 9Burleigh ME, Babaev VR, Oates JA, et al. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice. Circulation, 2002,105:1816-1823.
  • 10Cipollone F, Prontera C, Pini B, et al. Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E2-dependent plaque instability. Circulation, 2001,104:921-927.

共引文献14

同被引文献27

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部